City
Epaper

Manufacturing at Noida-based pharma company halted: Health Minister amid Uzbekistan's cough syrup deaths claim

By ANI | Updated: December 30, 2022 19:55 IST

Union Health Minister Mansukh Mandaviya on Friday said that all the manufacturing activities of the Noida-based pharma company have ...

Open in App

Union Health Minister Mansukh Mandaviya on Friday said that all the manufacturing activities of the Noida-based pharma company have been stopped in view of the reports of contamination in cough syrup Dok1 Max.

"Following inspection by @CDSCO_INDIA_INF [Central Drugs Standard Control Organisation] team in view of reports of contamination in cough syrup Dok1 Max, all manufacturing activities of Marion Biotech at NOIDA unit have been stopped yesterday night, while further investigation is ongoing," Mansukh Mandaviya said in a tweet.

Noida-based pharma Marion Biotech has come under a cloud as reports of children dying after consuming cough syrup made here came in from Uzbekistan. The matter is under investigation.

The company is waiting for the reports as it needs to be found out why cases came from a single hospital in Uzbekistan.

"We await the reports, factory was inspected. We have halted the production of all medicines. It needs to be found why cases came from a single hospital there. Our products also go to other countries," Marion Biotech Pharma Company legal head Hasan Harris said.

Health Ministry of Uzbekistan had claimed on Wednesday that as many as 18 children had died of acute respiratory disease after consuming cough syrup manufactured by Indian pharmaceutical firm Doc-Max.

On Thursday, the Indian mission in Uzbekistan expressed condolences to the family members of children who died allegedly due to consumption of contaminated cough syrup Dok1 Max, made by Noida-based Marion Biotech.

The Indian mission said the Central Drugs Standard Control Organisation (CDSCO) of India has also maintained regular contact with the national drug regulator of Uzbekistan since December 27, under the direction of the India Health Ministry.

The statement from the embassy further said the samples of the cough syrup have been taken from the manufacturing premises and sent to the Regional Drugs Testing Laboratory (RDTL) in Chandigarh, India for testing.

( With inputs from ANI )

Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

Tags: Hasan HarrischandigarhUzbekistanMansukh MandaviyaUnion HealthChandigarh union territoryCdscoCentral drugs standard control organisationStandard committeeCentral drugs standard control organizationMayor of south delhi municipal corporation
Open in App

Related Stories

NationalChandigarh: Air Raid Sirens Sound as Threat of Possible Attack from Pakistan Looms

NationalSirens Heard, Blackout Imposed In Chandigarh Amid Rising India-Pakistan Tension

NationalBody of Indian Student Vanshika Saini Found on Ottawa Beach in Canada

NationalVinod Sehwag, Brother of Former Cricketer Virender Sehwag, Arrested by Chandigarh Police in Cheque Bounce Case

MumbaiMumbai: Hollywood Actress Cheated on Pretext of Marriage, Accused Arrested from Chandigarh

National Realted Stories

National'Bhay binu hoy na preet': Operation Sindoor sends Ramayana-era message to Pakistan

National‘Pakistan bowed before PM Modi’: Kumaraswamy lauds success of Operation Sindoor

NationalBihar Congress launches QR code scanner for ticket aspirants ahead of Assembly polls

NationalAdani Group powers India's defence breakthrough with SkyStriker drones

NationalMartyred BSF man’s mortal remains to be brought to home state Manipur tomorrow